Get this course

Meetings and Conferences → ESO → ESO Conferences

ESOC 2021 - Virtual Conference


Description
ESOC 2021 happened as a virtual conference this year, due to the ongoing COVID pandemic. However, the very high quality of the science was maintained with a huge range of talks covering the whole range of stroke medicine.

Type of Course: Collection Year of Creation: 2021 Source: ESO Conference Content Level: Collection

Content
  • Scientific Session 1 - Clinical Challenges in iv Thrombolysis
  • Blood Pressure Management During and After Intravenous Thrombolysis: curtze
  • Intravenous Thrombolysis for Low NIHSS? Daniel Strbian
  • Tenecteplase: Is the End of Alteplase Approaching? Shelagh Coutts
  • Intravenous Thrombolysis in the Extended Time Window Götz Thomalla
  • Adjunct Therapeutic Options for Intravenous Thrombolysis: Shivering Lights in th
  • Scientific Session 2 - Recovery after stroke: a new era?
  • What Is Evidence Based in Stroke Rehabilitation? Katharina Stibrant
  • Vagus Nerve Stimulation: Experimental Data and Clinical Evidence Seth Hays
  • Non-invasive Neurostimulation for Dysphagia Treatment - Pros and Cons Rainer Dzi
  • Physical Activity After Stroke: What Is the Right Timing and Dose? Agnes Flöel
  • Recovery After Stroke: Are We Entering a New Era?
  • Wearables in Stroke Rehabilitation Arun Jayaraman
  • Scientific Session 4 - Stroke and Inflammation
  • Insights Into Post-Stroke Immunity – Pre-Clinical Evidence Kate Lykke Lambertse
  • Infection Preceding Stroke and Complicating Stroke - Epidemiological Evidence:
  • Response of Brain to COVID -19, Preclinical and Clinical Data Laura Benjamin
  • Inflammation as a Target in Stroke Prevention Angel Chamorro
  • Scientific Session 5 - Secondary Prevention What we should know
  • Interaction of Aging and Stroke: Cellular and Molecular Level Lukáš Valihrach
  • Antiplatelet Therapy for Stroke Prevention Peter Ringleb
  • Multimodal Intensified Secondary Prevention Programmes Heinrich J Audebert
  • Biomarkers to Guide Secondary Stroke Prevention With Anticoagulants Mira Katan
  • Scientific Session 6 - Sex Differences in Stroke
  • Pre-Eclampsia/Eclampsia and Menopause As Risk Factors Hannele Laivuori
  • Sex Differences in Risk Factors of Stroke Including Age Sanne Peters
  • Translational Stroke Research Sex and Age Matter Louise McCullough
  • Underrepresentation of Women in Trials: Impact on External Validity Aneesh B. Si
  • Scientific Session 7 - Targeting Cardiac Disease in Stroke Prevention
  • Suspected Cardio Embolic Stroke, Which Evaluation? Marta Rubiera
  • Occult Atrial Fibrillation and Embolic Stroke Renate Schnabel
  • Management of PFO-related Stroke Jan Kovac
  • What’s Best for the Heart Is Best for the Brain? Jan Scheitz
  • Scientific Session 8 - Pre-hospital stroke Medicine
  • Ambulance Service to Hospital: What is necessary to optimise the managementa?
  • Clinical Scores for Identification of LVO Patients; Tuukka Puolakka
  • The Role of Telemedicine in the Pre-Hospital Stroke Management Michael Mazya
  • Pre-Hospital Stroke Treatment – Where Are We Now? Philip Bath
  • Mobile Stroke Units for Pre-Hospital Triage and Thrombolysis Karianne Larsen
  • Scientific Session 9: ICH 1: Genetics, Secondary Prevention and Brain
  • Genetics of Intracranial Aneurysms Ynte M. Ruigrok
  • Medical and Non-medical Measures to Prevent Rupture Mervyn Vergouwen
  • Microbleeds: Black Sheep in Secondary Stroke Prevention? Meike Vernooij
  • Secondary Prevention After Hypertensive ICH Candice Delcourt
  • Scientific Session 10: Sources of Thromboembolism Beyond Atrial Fibrillation
  • Concept of Atrial Cardiopathy Hooman Kamel
  • Biomarkers of Cardiac Thromboembolism and Atrial Cardiopathy Alejandro Bustamant
  • Cancer Associated Thromboembolism Nicolas Martinez-Majander
  • PFO, Stroke Risk and Management in Older Patients Sara Mazucco
  • Cardiac Tumours and Stroke Risk and Management Madalena Rosário
  • Scientific Session 11: Acute Stroke Treatment in Difficult Clinical Situations
  • Thrombolysis in Patients With Recent Surgery or Trauma Gordian Hubert
  • The Older Patient With Extensive Medical History: What to Do? Marjaana Tiainen
  • Stroke in the Cath Lab and Related Situations Rajiv Advani
  • Thrombus Composition in Diverse Stroke Aetiologies; Marco Bacigaluppi
  • Acute Ischemic Stroke in Patients Suspected of COVID-19 Claudio Baracchini
  • Scientific Session 12: Intracerebral Hemorrhage II: Causes, Classification
  • Emerging Evidence for Alternative Classifications of ICH David Seiffge
  • Cerebral Amyloid Angiopathy Diagnosis: The Boston Criteria 2.0 David Werring
  • CSF and PET Biomarkers in Cerebral Amyloid Angiopathy Gargi Banerjee
  • Cerebral Amyloid Angiopathy-Related Inflammation: Fabrizio Piazza
  • Scientific Session 13: Non-Reperfusion Therapies for Acute Ischemic Stroke
  • DAPT for Minor Acute Ischemic Stroke: Clopidogrel vs. Ticagrelor Pierre Amarenco
  • Sphenopalatine ganglion stimulation for ischemic stroke ? Maia Beridze
  • Intravenous Glyburide for Cerebral Edema? Hanne Christensen
  • Nerinetide for LVO Neuroprotection: Fact or Fiction? Michael Hill
  • Factor XLA Inhibitors for Minor Acute Ischemic Stroke? Mike Sharma
  • Scientific Session 14: Current Status on the Diagnosis and Management of Intrac
  • Intracranial Stenosis: The Magnitude of the Condition Nicola Logallo
  • Intracranial Vessel Wall in MRI Jeroen Hendrikse
  • Medical Management of Intracranial Stenosis Elsa Azevedo
  • AI in Diagnosis of Acute Stroke – Accuracy in Hospital Triage Simon Nagel
  • Scientific Session 15: Making Artificial Intelligence Work for Stroke
  • AI in Diagnosis of LVO Pre Acute Stroke Treatment Grant Mair
  • AI in Delivery and Monitoring of Acute Therapies Geert Vanhooren
  • AI and Big Data in Predicting Outcome Susanne Wegener
  • Artificial Intelligence in Stroke Prevention Serefnur Ozturk
  • Scientific Session 17: Small Vessel Diseases
  • Monogenic Small Vessel Diseases: Which When and Why to Look for Them Hugh Markus
  • CADASIL: Present Knowledge and Future Perspectives Hugues Chabriat
  • Microvascular Matrisome Damage in SVDs Karen Horsburgh
  • Blood Brain Barrier Permeability in SVDs Julie Staals
  • Inflammatory Mechanisms in SVD Tushar Deshpande
  • Scientific Session 18: Large Artery Stroke: Carotid Disease, Plaque and Beyond
  • Cervical Artery Dissection Christopher Traenka
  • In Vivo Imaging and Blood Biomarkers of Carotid Plaque Inflammation Peter Kelly
  • Carotid Plaque Composition and Implications for Stroke Aetiologies Johanna Ospel
  • Differences Between Anterior and Posterior Circulation Karin Klijn
  • Scientific Session 19: Improving Efficiencies of Stroke Research
  • Approaches to Consent in Stroke TrialsMichel Shamy
  • Is the Modified Rankin Scale (OHS) Adequate to Measure Outcome? Jesse Dawson
  • Big Data in Stroke: Opportunities and Limitations Liping Liu
  • Predicting the Efficacy of Drugs by Mendelian Randomization Marios Georgakis
  • Strategic Lesion Location in VCI J. Matthijs Biesbroek
  • Computer-Based Cognitive Rehabilitation and Novel Technologies Katrine Sværke
  • Scientific Session 20: Vascular Cognitive Impairment
  • The Spectrum of Vascular Cognitive Impairment Hanna Jokinen
  • Cognitive Impairment, Covert Brain Lesions and Stroke Anil ManTuladhar
  • Underdiagnosed Conditions Mimicking Cognitive Impairment Zuzana Gdovinova
  • Scientific Session 21: Targeting the Vasculature to Improve Stroke Prevention
  • Pericytes, Blood Brain Barrier and Cerebrovascular Health Axel Montagne
  • Brain Capillary Sphincters and Pericytes Martin Lauritzen
  • Leptomeningeal Collaterals in Ischemic Stroke Marylin Cipolla
  • Perivascular Spaces in Stroke – Preclinical Insights Humberto Mestre
  • Visible Perivascular Spaces in Humans Yilong Wang
  • Scientific Session 22: Socio-Economics of Stroke
  • Economic Impacts of Stroke Jossup Kim
  • Costs and Return on Investment of Preventing and Treating Stroke Atte Meretoja
  • Access to Care and Socio-Economic Status Marie Eriksson
  • Socio-Economic Status as a Risk Factor of Stroke. Benjamin Bray
  • Scientific Session 23: Maximizing Quality of Life After Stroke: Focusing on Need
  • Maximizing Quality of Life After Stroke and Palliative Care? Gillian Mead
  • Impact of Aphasia on Quality of Life After Stroke Iwona Sarzyńska-Długosz
  • Communicating Prognosis After Stroke Claire Creutzfeldt
  • Treatment Decisions and Advance Directives in Severe Strokes Bart van der Worp
  • Caring for the Caregiver After Stroke Audrey Bowen
  • Scientific Session 24: Stroke Care for All Geographic and Economic Levels
  • Early Supported Discharge in Low- and Middle-Income Regions? Peter Langhorne
  • Optimising Stroke Care for Living Well with AphasiaMolly Manning
  • Telerehabilitation Services for Stroke in Remote Communities Kate Laver
  • Acute Care Pathways for Regional Stroke Services Panayiotis Mitsias
  • Scientific Session 25: Uncertain, Uncommon or Underdiagnosed Causes of Stroke
  • Embolic Stroke of Uncertain Source: Search of the Best Definition George Ntaios
  • Intracranial Dilatative Arteriopathy Fernando Pico
  • Moyamoya Arteriopathy: Differences Between Eastern and Western Anna Bersano
  • Fibromuscular Dysplasia and Cerebrovascular Manifestations Marion Boulanger
  • Scientific Session 26: Inflammation, Thrombosis and Stroke Pathogenesis
  • Platelets in Thromboinflammation Bernhard Nieswandt
  • Thrombosis in Microvenules After Arterial Occlusion Benoît Ho-Tin-Noé
  • Neutrophils in Stroke Pathogenesis Maria Angeles Moro
  • Perivascular Inflammation in Chronic Microvascular Disease Constantino Iadecola
  • Therapeutic Modulation of the Complement Cascade in Stroke E. Sander Connolly Jr
  • Teaching Course 1 - Intracerebral Haemorrhage
  • Modelling Intracerebral Hemorrhage Pathophysiology: From Vessel Rupture
  • Neuroimaging in Intracerebral Hemorrhage Grégoire Boulouis
  • Short-Term and Long-Term Prognosis After ICH: Ethical Dilemmas Marialuisa Zedde
  • Therapeutics Interventions for Spontaneous Intracerebral Hemorrhage Charlotte Co
  • Teaching Course 2 - Stroke Unit Care and Logistics
  • Definition and Benefits of a Stroke Unit Christine Roffe
  • Ultra-Fast IVT Delivery – Making It Happen Soffien Chadli Ajmi
  • Practical Neurosonology in the Stroke Unit Rossana Tassi
  • Teaching Course 3: Clinical Challenges in Posterior Circulation Ischemic Stroke
  • Challenges in Diagnosis of Posterior Circulation Stroke Dejana Jovanovic
  • Diagnostic Challenges in Posterior Circulation Stroke Branko Malojcic
  • Management of Posterior Circulation Stroke: Endovascular Treatment Andrea Zini
  • Life and Health after Posterior Circulation Stroke Ana Catarina Fonseca
  • Teaching Course 4: Carotid Disease and Stroke – An Update
  • Extracranial Atherosclerotic Carotid Disease Arijana Lovrencic Huzjan
  • Extracranial Non-Atherosclerotic Carotid Disease Emmanuel Touzé
  • Intracranial Atherosclerotic Carotid Disease Petra Ijäs
  • Intracranial Non-Atherosclerotic Carotid Disease Dominique Herve
  • Teaching Course 5: Stroke in Systemic Disease: Diagnostics and Treatment
  • Cerebrovascular Disease in Inflammatory Arthropathies David Hunt
  • Prothrombotic Conditions and Stroke Georgia Kaiafa
  • Giant Cell Arteritis and Stroke Yannick Béjot
  • Primary CNS Vasculitis. Diagnosis and Treatment? Albert Hietala
  • Whole exome sequencing reveals HTRA1 protease Rainer Malik
  • Teaching Course 6: Transient Symptoms - Stroke or Not?
  • The Transient Ischemic Attack,Who Is at Risk and Who to Send Home Kristina Szabo
  • How to Differentiate Between Migraine With Aura and TIA Ewoud van Dijk
  • The Transient Mimic Áine Merwick
  • How Did I End Up Here? The Clinical Features of a TGA Thorsten Bartsch
  • Stroke or Seizure? Francesco Brigo
  • Teaching Course 8: Intravenous Thrombolysis
  • IVT – Is There a Role for a Lower Dose? Thompson Robinson
  • A Shift in Standards: Beyond a 4.5 Hour Time Window Amanda Jagolino-Cole
  • The Benefit and Practical Aspects of Certification Joaquin Carneado-Ruiz
  • Tenecteplase – When and Why? Adam Kobayashi
  • Teaching Course 9 Neuro-imaging in Stroke
  • Brain CT Diagnose ICH Due to Cerebral Amyloid Angiopathy? Rustam Al-Shahi Salman
  • Magnetic Resonance Imaging Before Treatment:Ischemic Stroke Catherine Oppenheim
  • Magnetic Resonance Imaging Before Treatment Catherine Oppenheim
  • CT Perfusion in the Acute Setting: Stroke and Alternative Diagnosis Robin Lemmen
  • MRI for Patients Presenting With TIA Ivana Galinovic
  • The Role of Stroke Unit and Stroke Center Certification Diederik W. Dippel
  • Teaching Course 10: Neurosonology
  • Introducing Neurosonology Christine Kremer
  • Improving Large Vessel Diagnostic Sverre Rosenbaum
  • Role of Ultrasound in Clinical Decision Making Christos Krogias
  • Transcranial Doppler Explained Fabienne Perren
  • Teaching Course 11: Cerebral Venous Thrombosis
  • Imaging in CVT Mikael Mazighi
  • CVT after vaccination for COVID Jonathan Coutinho
  • Prognosis and Outcomes in CVT Jose Ferro
  • Pregnancy During and After CVT Marina Diomedi
  • Teaching Course 12: Monogenic Causes of Stroke
  • Consider a Genetic Cause of Small Vessel Disease? Saskia Lesnik Oberstein
  • Stroke in Children and Young Adults. Heather Fullerton
  • Ischemic Stroke Without a Cause. When to Call the Geneticist? Andreea Ilinca
  • Teaching Course 13: Practical Management of Stroke: Pregnancy
  • Incidence and Risk Factors During and After Pregnancy Karoliina Aarnio
  • Doctor, Can I Become Safely Pregnant After My Stroke? Marc Spaanderman
  • COVID-19 : Aetiologies, Short and Potential Long-Term Effects Elena Moro
  • Management of Acute Ischemic Stroke During Pregnancy Diana Aguiar de Sousa
  • Secondary Prevention During Pregnancy; Mia von Euler
  • Multi-discipliniary Session 1 - Publishing a Paper
  • How to Prepare a Paper for Submission? Bo Norrving
  • What Happens After Submission? Hugh Markus
  • The Future of Publishing Helen Frankish
  • Technology / Multi-discipline / Beyond Medicine - Session 2 Guidelines
  • ESO Guideline on Dissections Stephanie Debette
  • Guideline for the Diagnosis and Treatment of PostStroke Dysphagia Rainer Dziewas
  • Technology / Multi-discipline / Beyond Medicine - Session 3 Controversies
  • The computer says ‘no’’
  • I have white spots in my brain – what should I do?’ Chris Chen / Alastair Webb
  • Allied Health Care Session 2- Fundamentals 2
  • Nursing in the Hyperacute Phase - The Finnish Model Johanna Martin
  • Early Mobilisation & Hemiplegic Shoulder Pain Martine Nadler
  • Supporting Lifestyle Changes and Health Promotion: Stroke CARD Peter Willeit
  • Allied Health Care Session 3: Upper-Limb Assessment, Interventions and Implement
  • Upper Limb Sensorimotor Assessment Using Technology Pavel Lindberg
  • Implementation in clinical practice– Challenges and Possibilities Louise Connell
  • Consensus on Standardized (Quality of Movement) Measurement Jane Helena Burridge
  • Standardized Assessments in Clinical Practice Rinske Nijland
  • Potential Benefits of PREP2 in Clinical Practice Cathy M. Stinear
  • Allied Health Care Session 4) Return to Work, Participation, Social Prescribing
  • RTW Interventions Kathryn Radford
  • Return to Life and Leisure After Stroke Matthew Reeves
  • Return to Work after Specialized Rehabilitation for People Birgitta Langhammer
  • Return to Work and Depression After Stroke Matthias Volz
  • Long-term Follow Hanna Persson
  • Allied Health Care Session 5) Severe Stroke
  • Rehabilitating the Upper Limb in Severe Stroke Kate Hayward
  • Non-Invasive Brain Stimulation Effects on Motor Function Charlotte Stagg
  • What Makes Severe Stroke Even Worse: Frailty Terrence Quinn
Completion rules
  • All units must be completed
Back